An approach to the patient with retiform purpura
- PMID: 21410606
- DOI: 10.1111/j.1529-8019.2011.01392.x
An approach to the patient with retiform purpura
Abstract
Retiform purpura consists of branching purpuric lesions caused by a complete blockage of blood flow in the dermal and subcutaneous vasculature. The differential diagnosis for retiform purpura is broad, including vasculitides of the small and medium vessels as well as microvascular occlusion due to thrombotic, infectious, and embolic phenomena. Determining the etiology of this important dermatologic sign can be a diagnostic challenge; however, an organized approach can improve the speed and accuracy of diagnosis and identify an effective treatment. This review focuses on early recognition, evaluation, and treatment of hospitalized patients with retiform purpura. Specifically, vasculitis, protein C and S deficiencies, heparin necrosis, warfarin necrosis, antiphospholipid antibody syndrome, disseminated intravascular coagulation, cryoglobulinemia, calciphylaxis, and cholesterol embolization syndrome will be discussed in detail. These conditions are commonly seen in consultative dermatology and can have multiorgan involvement, complicated laboratory evaluation, and long-term therapeutic implications.
© 2011 Wiley Periodicals, Inc.
Similar articles
-
Retiform purpura: Workup and therapeutic considerations in select conditions.J Am Acad Dermatol. 2020 Apr;82(4):799-816. doi: 10.1016/j.jaad.2019.07.113. Epub 2019 Aug 31. J Am Acad Dermatol. 2020. PMID: 31479690 Review.
-
Retiform purpura in plaques: a morphological approach to diagnosis.Clin Exp Dermatol. 2007 Sep;32(5):596-602. doi: 10.1111/j.1365-2230.2007.02423.x. Epub 2007 May 8. Clin Exp Dermatol. 2007. PMID: 17489989
-
A detailed analysis of the distribution, morphology, and histopathology of complex purpura in hospitalized patients: A case series of 68 patients.J Am Acad Dermatol. 2021 Apr;84(4):1188-1196. doi: 10.1016/j.jaad.2020.04.149. Epub 2020 May 4. J Am Acad Dermatol. 2021. PMID: 32376433
-
An approach to the hospitalized patient with urticaria and fever.Dermatol Ther. 2011 Mar-Apr;24(2):187-95. doi: 10.1111/j.1529-8019.2011.01394.x. Dermatol Ther. 2011. PMID: 21410608 Review.
-
Retiform purpura: A diagnostic approach.J Am Acad Dermatol. 2020 Apr;82(4):783-796. doi: 10.1016/j.jaad.2019.07.112. Epub 2019 Aug 31. J Am Acad Dermatol. 2020. PMID: 31479689 Review.
Cited by
-
COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report.Clin Case Rep. 2022 Dec 27;10(12):e6790. doi: 10.1002/ccr3.6790. eCollection 2022 Dec. Clin Case Rep. 2022. PMID: 36590660 Free PMC article.
-
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027. Dermatopathology (Basel). 2022. PMID: 35892480 Free PMC article. Review.
-
Skin manifestations associated with systemic diseases - Part I.An Bras Dermatol. 2021 Nov-Dec;96(6):655-671. doi: 10.1016/j.abd.2021.02.008. Epub 2021 Sep 17. An Bras Dermatol. 2021. PMID: 34544638 Free PMC article.
-
Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection.J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e839-e841. doi: 10.1111/jdv.17562. Epub 2021 Aug 4. J Eur Acad Dermatol Venereol. 2021. PMID: 34309085 Free PMC article. No abstract available.
-
Widespread cutaneous vasculopathy associated with levamisole-adulterated cocaine.Indian J Dermatol Venereol Leprol. 2021 [SEASON];87(4):540-542. doi: 10.25259/IJDVL_986_20. Indian J Dermatol Venereol Leprol. 2021. PMID: 34114415 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
